CClinicalTrials.gg
CompletedNCT02432131DIVER-PFOUpdated Aug 24, 2021

Decompression Sickness in Divers With or Without Patent Foramen Ovale

An observational study in Foramen Ovale, Patent and Decompression Sickness, sponsored by Sejong General Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-08-24.

Sponsored by Sejong General Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

The investigators will prospectively estimate incidences of decompression sickness in SCUBA divers with or without patent foramen ovale (PFO). All participants will receive transesophageal echocardiogram and transcranial doppler to ascertain whether they get a PFO. Clinical follow up will be undertaken 3 month after transesophageal echocardiographic evaluation, and every 6 month up to 3 years by E-mailing or telephone interview with self-questionnaire report. All decompression sickness (DC) events or DC-like symptoms will be reviewed by a professional diver, who is a medical doctor and member of DAN-AP, and a neurologist.

Read the detailed description

PFO was defined as transesophageal echocardiographic (TEE) evidence of infused microbubbles in the left atrium within three cardiac cycles after their appearance in the right atrium, at rest or during Valsalva release. If TEE finding will not be conclusive, we will decide the presence or absence of PFO with supplementary transcranial doppler. It will be blinded to participants, physicians and research persons to perform clinical follow-up. It will be not officially recorded, and will be preserved by another research person, who will not contact study participants.

02

Conditions studied

  • Foramen Ovale, Patent
  • Decompression Sickness
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Recreational or occupational SCUBA (self-contained underwater breathing apparatus) divers

Inclusion criteria

  • Divers who experienced fifty dives per year

Exclusion criteria

Exclusion Criteria:

  • Decompression sickness within recent 20 dives
  • Previous procedure or surgery for closure of PFO or ASD
  • Previous cerebral infarction or hemorrhage
  • Previous epilepsy
  • Previous angina or myocardial infarction
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (actual)
Target follow-up
3 Years
Patient registry
Yes

Groups and cohorts

  • Divers with PFO
  • Divers without PFO
05

What researchers measure

Primary outcomes

  1. PFO-related decompression sickness

    Three-year cumulative incidences of cutaneous or neurological decompression sickness, all symptoms requiring recompression chamber therapy, all symptoms developed during ascending or within 30minute after surfacing, or unexplained death within 2 weeks after diving

    Time frame: Three years

Secondary outcomes

  1. Cutaneous or neurological decompression sickness

    Time frame: Three years

  2. All symptoms requiring recompression chamber therapy

    Time frame: Three years

  3. All symptoms developed during ascending or within 30minute after surfacing

    Time frame: Three years

  4. Unexplained death within 2 weeks after diving

    Time frame: Three years

06

Study locations

1 site
  • Sejong general hospital, 91-121 Sosa 2-Dong, Sosa-Gu
    Bucheon, Gyeonggi 422-711, Korea, Republic of
07

Registry details

Key details

Study ID
NCT02432131
Lead sponsor
Sejong General Hospital
Collaborators
Sejong Research Institute
Responsible party
Hyun Jong Lee (MD, PhD, Sejong General Hospital) — Principal investigator
First posted
May 1, 2015
Start date
May 2015
Primary completion
Feb 2021
Completion
Feb 2021
Last update
Aug 24, 2021

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion